DSpace About DSpace Software 日本語
 

GINMU >
01 奈良県立医科大学 >
011 医学部 >
0112 紀要 >
01121 Journal of Nara Medical Association >
Vol.63 No.3-4 >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10564/2374

Title: 当科における耐術能不良な食道がん症例に対する集学的治療の現状 : 特に高齢者治療の観点から
Other Titles: OUR STRATEGY FOR INTENSIVE TREATMENT AGAINST UNRESECTABLE ADVANCED ESOPHAGEAL CANCER IN ELDERLY PATIENTS
Authors: 古川, 政統
守屋, 圭
美登路, 昭
吉田, 太之
沢井, 正佳
上嶋, 昌和
浪崎, 正
藤永, 幸久
大谷, 絵美
辰巳, 晴規
鍛治, 孝祐
相原, 洋祐
堂原, 彰敏
高谷, 広章
武山, 真也
津呂, 公規
森岡, 千惠
野口, 隆一
池中, 康英
豊原, 眞久
吉治, 仁志
藤本, 正男
植村, 正人
福井, 博
山尾, 純一
Keywords: 食道腫瘍
扁平上皮癌
放射線化学療法
治療成績
アルゴリズム
高齢者
Issue Date: 31-Aug-2012
Publisher: 奈良医学会
奈良県立医科大学
Citation: Journal of Nara Medical Association Vol.63 No.3-4 p.47-53
Abstract: In this study, we examined the features of patients with advanced unresectable squamous cell carcinoma of the thoracic esophagus in our hospital and validated our strategy of intensive treatment. The average age of our patients was higher than those reported by other facilities and our elderly patients had various kinds of complications. We basically performed either chemoradiation (CRT) or radiation (RT) therapy for these patients with unresectable esophageal cancer. Median survival time of the intensively treated patients with CRT/RT was almost twice longer than those with only best supportive care. An improved food intake was noted in two-thirds of our patients after CRT/RT because of tumor shrinkage. For the less collapsing ratio of CRT, we chose concurrent CRT with low-dose cisplatin (CDDP) plus continuous infusion of 5-fluorouracil (LDFP) especially to elderly patients. Actually, in our hospital, the incidence of hematotoxicity by LDFP was distinctly lower compared with the standard-dose CDDP plus continuous infusion of 5-fluorouracil (SDFP). Additionally, new combination chemoradiotherapy with cisdiammine-glycolate platinum (Nedaplatin) and 5-fluorouracil was given to patients with advanced esophageal cancer and other organ metastasis. Nedaplatin has been known to be less toxic for kidney and digestive organs and to show much stronger antitumor activity compared to CDDP in patients with esophageal cancer. Our overall CRT/RT outcome should be acceptable, if taking patients' ages and their various complications into consideration. We recognized the necessity of making an appropriate medical decision in each elderly patient receiving intensive treatment against unresectable advanced esophageal cancer and of managing adverse effects of CRT/RT promptly for attaining good prognosis and high quality of life.
URI: http://hdl.handle.net/10564/2374
ISSN: 13450069
Appears in Collections:Vol.63 No.3-4

Files in This Item:

File Description SizeFormat
47-53p:当科における耐術能不良な食道がん症例に対する集学的治療の現状:特に高齢者治療の観点から.pdf4.33 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback